Company / Capital Expenditures
Cytokinetics Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$24.8M
FY2025
5-year range
$1.4M / $48.9M
FY2021-FY2025
Trend
+535.1%
vs FY2024
Sector context
#41 of 194
Health Care
What the data says
Capital Expenditures changed +535% YoY in FY2025, a notable deviation from the 9-year average annual change of +157%.
Based on SEC 10-K filings.
$25M in FY2025 with a 5-year CAGR of +17.6%. Top quartile in the Health Care sector.
Improved from $1M to $25M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +29.8%
- 5-Year CAGR
- +17.6%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 194This company $24.8M Sector average $117.5M
▼
-78.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +17.6%, indicating consistent growth.
- In FY2025, capital expenditures increased 535.1% year-over-year.
- Ranks #41 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.8M | +535.1% |
| FY2024 | $3.9M | +175.8% |
| FY2023 | $1.4M | -87.5% |
| FY2022 | $11.3M | -76.8% |
| FY2021 | $48.9M | +342.2% |
| FY2020 | $11.1M | +322.0% |
| FY2019 | $2.6M | +194.6% |
| FY2018 | $889.0K | -69.1% |
| FY2017 | $2.9M | +80.3% |
| FY2016 | $1.6M | +184.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026